Literature DB >> 20086160

Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.

Elizabeth M Brown1, David N Fisman, Steven J Drews, Sharon Dolman, Prasad Rawte, Shirley Brown, Frances Jamieson.   

Abstract

Neisseria meningitidis has been relatively slow to acquire resistance to penicillin. We previously reported an increase in the incidence of invasive meningococcal disease (IMD) strains with decreased susceptibility to penicillin (DSP) in Ontario. Our objectives were to evaluate trends in IMD with DSP, to identify case-level predictors of IMD with DSP, and to evaluate the relationship among DSP, bacterial phenotype, and the likelihood of a fatal outcome. All IMD isolates received in Ontario between 2000 and 2006 were submitted to the Public Health Laboratories, Toronto, for confirmation of the species, serogroup determination, and susceptibility testing. Isolates were considered to be IMD strains with DSP if the penicillin MIC was > or =0.125 microg/ml. Temporal trends were evaluated using multivariable Poisson regression models. Correlates of diminished susceptibility and fatal outcome were evaluated with multivariable logistic regression models. The overall rate of IMD caused by strains with DSP in Ontario was approximately 1.20 cases per million population annually (95% confidence interval [95% CI], 0.99 to 1.46). Seventy-nine strains (21.7%) were IMD strains with DSP. There was no year-to-year trend in the incidence of IMD with DSP. IMD with DSP was strongly associated with strains of serogroups Y (odds ratio [OR], 6.3; 95% CI, 3.6 to 11.1) and W-135 (OR, 8.2; 95% CI, 4.0 to 16.7). Infection with serogroup B or C strains was associated with a marked increase in the risk of mortality (OR, 3.07; 95% CI, 1.39 to 6.75); however, no association between IMD with DSP and mortality was observed. In contrast to trends of the 1990s, the incidence of IMD with DSP was stable in Ontario between 2000 and 2006. In Ontario, the serogroup rather than the penicillin MIC is the microbiological parameter most predictive of mortality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20086160      PMCID: PMC2826021          DOI: 10.1128/AAC.01077-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

Review 1.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

Review 2.  Impact of meningococcal C conjugate vaccine in the UK.

Authors:  P Balmer; R Borrow; E Miller
Journal:  J Med Microbiol       Date:  2002-09       Impact factor: 2.472

3.  Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001.

Authors:  Raymond Sw Tsang; Susan G Squires; Wendell D Zollinger; Fraser E Ashton
Journal:  Can J Infect Dis       Date:  2002-11

4.  Penicillin resistance in Neisseria meningitidis.

Authors:  G Riley; S Brown; C Krishnan
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

5.  Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994-1999.

Authors:  J W Tapsall; T Shultz; E Limnios; R Munro; J Mercer; R Porritt; J Griffith; G Hogg; G Lum; A Lawrence; D Hansman; P Collignon; P Southwell; K Ott; M Gardam; C J Richardson; J Bates; D Murphy; H Smith
Journal:  Pathology       Date:  2001-08       Impact factor: 5.306

6.  [Fatality rate in the epidemiology of meningococcal disease: study in the region of Campinas, SP, Brazil, 1993 to 1998].

Authors:  M R Donalisio; B Kemp; M M Rocha; R M Ramalheira
Journal:  Rev Saude Publica       Date:  2000-12       Impact factor: 2.106

7.  Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.

Authors:  R S W Tsang; S G Squires; T W S Tam
Journal:  Can J Microbiol       Date:  2003-10       Impact factor: 2.419

8.  Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county.

Authors:  Elise Snitker Jensen; Henrik C Schønheyder; Inga Lind; Lene Berthelsen; Bente Nørgård; Henrik Toft Sørensen
Journal:  J Med Microbiol       Date:  2003-02       Impact factor: 2.472

9.  Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis.

Authors:  Elizabeth A Mothershed; Claudio T Sacchi; Anne M Whitney; Gwen A Barnett; Gloria W Ajello; Susanna Schmink; Leonard W Mayer; Maureen Phelan; Thomas H Taylor; Scott A Bernhardt; Nancy E Rosenstein; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns.

Authors:  Aude Antignac; Magaly Ducos-Galand; Annie Guiyoule; René Pirès; Jean-Michel Alonso; Muhamed-Kheir Taha
Journal:  Clin Infect Dis       Date:  2003-09-09       Impact factor: 9.079

View more
  10 in total

1.  Meningococcal meningitis.

Authors:  Ricardo G Branco; Robert C Tasker
Journal:  Curr Treat Options Neurol       Date:  2010-09       Impact factor: 3.598

2.  Antibiotic susceptibility and molecular analysis of invasive Neisseria meningitidis recovered in the Republic of Ireland, 1996 to 2016.

Authors:  Désirée E Bennett; K L Meyler; M T Cafferkey; R J Cunney
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-05       Impact factor: 3.267

3.  Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age.

Authors:  Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2014-03       Impact factor: 2.253

4.  Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.

Authors:  Brian H Harcourt; Raydel D Anderson; Henry M Wu; Amanda C Cohn; Jessica R MacNeil; Thomas H Taylor; Xin Wang; Thomas A Clark; Nancy E Messonnier; Leonard W Mayer
Journal:  Open Forum Infect Dis       Date:  2015-08-13       Impact factor: 3.835

5.  Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009.

Authors:  Amy E Blain; Sema Mandal; Henry Wu; Jessica R MacNeil; Lee H Harrison; Monica M Farley; Ruth Lynfield; Lisa Miller; Megin Nichols; Sue Petit; Arthur Reingold; William Schaffner; Ann Thomas; Shelley M Zansky; Raydel Anderson; Brian H Harcourt; Leonard W Mayer; Thomas A Clark; Amanda C Cohn
Journal:  Open Forum Infect Dis       Date:  2016-07-13       Impact factor: 3.835

6.  Neisseria meningitidis Antimicrobial Resistance in Italy, 2006 to 2016.

Authors:  Paola Vacca; Cecilia Fazio; Arianna Neri; Luigina Ambrosio; Annapina Palmieri; Paola Stefanelli
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

7.  Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010.

Authors:  Vica Dang; Frances B Jamieson; Sarah Wilson; Prasad Rawte; Natasha S Crowcroft; Karen Johnson; Raymond S W Tsang; Shelley L Deeks
Journal:  BMC Infect Dis       Date:  2012-08-29       Impact factor: 3.090

8.  Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010.

Authors:  Ana Belén Ibarz-Pavón; Ana Paula Lemos; Maria Cecilia Gorla; Mabel Regueira; Jean-Marc Gabastou
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

9.  WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 β-lactamase gene.

Authors:  Raymond S W Tsang; Tauqeer Ahmad; Frances B Jamieson; Gregory J Tyrrell
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

10.  Epidemiological profile of Neisseria meningitidis in Casablanca, Morocco: 2010-2019.

Authors:  Khadija Ait Mouss; Aziza Razki; Eva Hong; Bahija Zaki; Fakhreddine Maaloum; Néhémie Nzoyikorera; Houria Belabbes; Naima Elmdaghri; Khalid Zerouali
Journal:  Access Microbiol       Date:  2020-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.